Deepbridge Capital
Status
ACTIVE
Global HQ
Chester, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- MedTech
- Digital Health
About
Deepbridge Capital focuses on investing in early-stage technology and life sciences startups in the UK, particularly those working in medtech, digital health, and sustainability. They use tax-advantageous EIS and VCT investment structures to help accelerate the growth of these startups, providing not only capital but also expert guidance. Deepbridge places a strong emphasis on the ability of these companies to achieve near-term commercial traction and sustainable long-term growth, making sure the ventures they back have the right management teams and resources to thrive in competitive markets.
Deepbridge Capital focuses on investing in early-stage technology and life sciences startups in the UK, particularly those working in medtech, digital health, and sustainability. They use tax-advantageous EIS and VCT investment structures to help accelerate the growth of these startups, providing not only capital but also expert guidance. Deepbridge places a strong emphasis on the ability of these companies to achieve near-term commercial traction and sustainable long-term growth, making sure the ventures they back have the right management teams and resources to thrive in competitive markets.
Investment Thesis
Deepbridge Capital’s investment thesis is grounded in supporting innovation-driven early-stage companies that demonstrate strong market demand and scalable IP. Through EIS and VCT structures, the firm mitigates investor risk while enabling growth in key UK sectors such as medtech, renewable energy, and digital technology. Deepbridge backs management teams that combine technical depth with commercial acumen, emphasizing revenue generation and capital efficiency. Its goal is to foster sustainable businesses that can deliver strong returns while contributing positively to technological progress and economic resilience.
Manager's Experience
Led by a team with strong backgrounds in private equity and venture capital, combining sector expertise in tech, healthcare, and energy.
Team
Ian Warwick- Managing Partner
Gareth Groome -ACA BFP Partner & Chief Financial Officer
Kieran O'Gorman -Technical Partner
Dr. Savvas Neophytou -Partner & Chief Investment Officer
Andrew Aldridge -Chief Operating Officer
Ben Carter Investment- Director
Head of Life Sciences
Fuchsia Curry -Commercial Director
Phillip Secrette- Operations Director
Anjali Roberts- Strategic Partnerships' Director
Ray Eugeni- Partner
Rick Parry-Partner Sandie Marshall- Finance Manager Senior Investment Team
Portfolio
AlgaeCytes
FinTech start-ups
sustainable tech
drug discovery
AI/VR
Blockchain
MedTech
agritech
therapeutics
health tech